Proof for EBV's sustaining role in Burkitt's lymphomas
- 22 July 2009
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 19 (6) , 389-393
- https://doi.org/10.1016/j.semcancer.2009.07.006
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survivalThe Journal of Experimental Medicine, 2008
- The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cellsThe EMBO Journal, 2007
- Truncated Form of the Epstein-Barr Virus Protein EBNA-LP Protects against Caspase-Dependent Apoptosis by Inhibiting Protein Phosphatase 2AJournal of Virology, 2007
- The plasmid replicon of Epstein–Barr virus: Mechanistic insights into efficient, licensed, extrachromosomal replication in human cellsPlasmid, 2007
- Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cellsProceedings of the National Academy of Sciences, 2006
- Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genesProceedings of the National Academy of Sciences, 2006
- Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of ApoptosisPLoS Biology, 2005
- Replacement of the Epstein-Barr Virus Plasmid with the EBER Plasmid in Burkitt's Lymphoma CellsJournal of Virology, 2001
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985
- Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell lineJournal of Molecular Biology, 1976